Akzo Nobel NV
AKZOY
AKZOY was delisted on the 24th of August, 2007.
8 hedge funds and large institutions have $63.3M invested in Akzo Nobel NV in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more capital invested
Capital invested by funds: $50.7M → $63.3M (+$12.6M)
14% more funds holding
Funds holding: 7 → 8 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
+$5.49M |
| 2 |
SCCM
Schafer Cullen Capital Management
New York
|
+$223K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$186K |
| 4 |
MCM
Mitchell Capital Management
Leawood,
Kansas
|
+$14.7K |
| 5 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
+$6.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FRA
Front Row Advisors
Tiburon,
California
|
-$16K |
AKZOY Hedge Fund Activity: Q3 2020 in Review
8 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Akzo Nobel NV (AKZOY) for Q3 2020, worth a combined $63.3M — up 25% from $50.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new AKZOY positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Aristotle Capital Management, adding an estimated $5.49M. The largest seller was Front Row Advisors, exiting entirely with an estimated $16K sold.
- 8 institutional investors held Akzo Nobel NV (AKZOY) as of Q3 2020, up from 7 in Q2 2020.
- Funds reported $63.3M of Akzo Nobel NV stock for Q3 2020, up 25% quarter-over-quarter.
- 2 funds opened new Akzo Nobel NV positions in Q3 2020 and 1 closed out, a net change of +1 holder.
- The largest Akzo Nobel NV buyer in Q3 2020 was Aristotle Capital Management, an estimated $5.49M added.
- The largest Akzo Nobel NV seller in Q3 2020 was Front Row Advisors, an estimated $16K sold.
Based on aggregated 13F filings for Q3 2020.